Target intelligence / Profile preview

Zinc finger protein 826 pseudogene (ZNF826P)

Target
ZNF826P
Molecular classification
Pseudogene, Zinc finger protein family, Putative DNA-binding transcription factor
01

Overview

Zinc finger protein 826 pseudogene (ZNF826P) is a predicted pseudogene belonging to the zinc finger protein family, which are known for their DNA-binding transcription factor activity and roles in transcriptional regulation. ZNF826P is predicted to enable DNA-binding transcription factor activity, and may be involved in the regulation of DNA-templated transcription, with localization in the nucleus[2]. However, being annotated as a pseudogene, it is not currently considered a functional protein-coding gene, nor is it recognized as a therapeutic target. There is no direct evidence linking ZNF826P to disease mechanisms, drug interactions, or biomarker status. Most functional zinc finger proteins are important in cell differentiation, genome stability, and development, but ZNF826P lacks established biological or clinical relevance in current literature[1][3][2].\n\nIf you need information about functional zinc finger proteins, such as those with established therapeutic relevance (e.g., KRAB domain-containing zinc finger proteins or engineered zinc finger nucleases), they will differ significantly from ZNF826P, which is classified and annotated as a pseudogene.

Other names
ZNF826PZinc finger protein 826, pseudogenePutative zinc finger protein 826ZNF826FLJ44894
02

Mechanism of action

Not applicable; no drugs are known to target this molecule

03

Biological functions

Predicted DNA-binding transcription factor activityRegulation of DNA-templated transcriptionLocalization in the nucleus
04

Disease associations

None established; roles of other zinc finger proteins may include cancer, genome stability, chemotherapy resistance, but no evidence for ZNF826P itself
05

Safety considerations

None reported; no known therapeutic applications or challenges associated with ZNF826P
06

Interacting drugs

None known; no drugs documented to target ZNF826P or modulate its function
07

Biomarkers

None known; ZNF826P is not an established biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Zinc finger protein 826 pseudogene (ZNF826P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 826 pseudogene (ZNF826P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call